期刊文献+

c-myc靶向siRNA真核表达载体的构建和鉴定 被引量:1

EstabIishment and Identification of siRNA Eukaryotic Expression Vectors of Recombinant Targeting Gene c-myc
下载PDF
导出
摘要 目的:设计构建重组体为转染肿瘤细胞,观察癌基因的沉默效果,为探索肿瘤基因治疗的新途径打好基础。方法:以c-myc为靶基因,以pEGFP-C1/U6质粒为载体,设计构建重组体,根据c-myc癌基因cDNA序列,设计有小发夹结构的3条寡核苷酸序列,克隆到空载体pEGFP-C1/U6中,转化DH5а菌株,提取质粒,进行酶切鉴定和测序分析。结果:经酶切鉴定筛出的重组体测序结果与目的序列相同,重组载体构建成功。结论:利用RNAi技术可成功构建小干扰RNA重组体。 Objective: To design and establish transfection tumor cells from recombinant, observe dumbness effect of oncogene, and explore the new method of gene therapy. Methods: Recombinant were designed and established by targeting gene c-myc and plasmid pEGFP-C1/U6 based on c-myc oncogene cDNA sequence. Three pairs of oligonucleotides were synthesized and inserted into plasmid pEGFP-C1/U6 to generate siRNA eukaryotic expression vectors. DH5a strains were transformed, plasmids were extracted, and the recombinant sequences were identified. Results: The result of recombinant sequence was the same as aim sequence. The recombinant vectors were established successfully. Conclusion: siRNA recombinant can be established successfully by RNAi technique.
出处 《天津医药》 CAS 北大核心 2005年第6期360-362,i001,共4页 Tianjin Medical Journal
基金 国家863计划资助课题(项目编号:2001AA218051)
  • 相关文献

参考文献7

  • 1Elbashir SM,Lendeckel W,Tuschel T.RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev,2001,15 (2): 188-200.
  • 2Yu JY,DeRuiter SL,Tumer DL. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells .Proc Natl Acad Sci USA,2002,99:6047.
  • 3Brummelkamp TR,Bemards R,Agami R. A system for stable expression of short interfering RNAs in mammalian cells.Science,2002,296(5567):550.
  • 4Smith DR,Myint T,Goh HS. Over-expression of the c-myc proto-on-co-gene i n Coloreetal Carcinoma.Br J Cancer, 1993 , 68 ( 6 ) :407-413.
  • 5Tsai LC,Hung MW,Yuan CC,et al. Effects of tamoxifen and retinoic acid on cell growth and c-myc expression in human breast an cervical cancer cells.Anticancer Res, 1997,17 ( 6D ) :4557 -4562.
  • 6Aoki Y, Cioca D, Oidaira H, et al. RNA interference may be more potent than antisense RNA in human cancer cell lines. Clin Exp Pharmacol Physiol,2003,30 ( 122 ) :96-102.
  • 7Fire A,Xu S,Montgomery MK,et al.Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.Nature,1998,391 (6669):806-811.

同被引文献8

  • 1马峻岭,刘卫东,张联,冯国双,赵洪军,游伟程.临朐县1980至2002年恶性肿瘤变化趋势分析[J].中华预防医学杂志,2006,40(6):405-408. 被引量:9
  • 2Illemann M, Bird N, Majeed A. MMP-9 is differentially expressed in primary human colorectal adenocarcinomas and their metastases[J]. Mol Cancer Res, 2006,4(5):293-302.
  • 3Miyagi SP, Hiraki KR, Martins MD,et al. Expression of matrix metalloproteinases 2 and 9 in odontogenic myxoma in vivo and in vitro [J]. J Oral Sci ,2008,50(2):187-192.
  • 4El Badry AA, El-Fadle AA, El-Balshy AL.Tissue inhibitor of matrix metalloproteinase-2 in nasopharyngeal carcinoma [J]. Med Gen Med ,2007,9(3):3.
  • 5Zhong WD, Hart ZD, He HC, et al. CD147, MMP-1, MMP-2 and MMP-9 protein expression as significant prognostic factors in human prostate cancer[J]. Oneology ,2008,75(3-4):230-236.
  • 6Martins S J, Takagaki TY, Silva AG, et al. Prognostic relevance of TTF-1 and MMP-9 expression in advanced lung adenocarcinoma [J]. Lung Cancer,2009,64(1 ) : 105-109.
  • 7Karadag N, Kirimlioglu H, Isik B, et al.Expression of matrix metalloproteinases in gallbladder carcinoma and their significance in carcinogenesis [J]. Appl Immunohistochem Mol Morphol,2008,16(2): 148-152.
  • 8Sun WH, Sun YL, Fang RN,et al. Expression of cyclooxygenase-2 and matrix metalloproteinase-9 in gastric carcinoma and its correlation with angiogenesis[J]. Jpn J Clin Oncol,2005,35(12):707-713.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部